This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berglund, G. Articles by Wikstrand, J. Search for Related Content PubMed PubMed Citation Articles by Berglund, G. Articles by Wikstrand, J.

Hypertension, Vol 7, 688-694, Copyright © 1985 by American Heart Association

ARTICLES

Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive device

G Berglund, U De Faire, J Castenfors, G Andersson, M Hartford, H Liedholm, S Ljungman, T Thulin and J Wikstrand

To test the usefulness of noninvasive ambulatory 24-hour blood pressure recording, the Del Mar Avionics system was used in a double-blind clinical trial in which 31 hypertensive patients were randomly allocated to receive placebo or pafenolol (25 mg or 50 mg), a novel, long-acting, highly selective beta-blocker, once daily. The results of 24-hour blood pressure and heart rate recording after 4 weeks of treatment were compared with a previous 24-hour recording performed after a 4-week placebo run-in period using the 3-hour mean of recordings performed every 7.5 minutes both day and night. Furthermore, 24-hour means were analyzed in each patient before and after 4 weeks. The system was easy to use and, judging from two placebo periods in the same patients, the reproducibility was good. The 24-hour blood pressure and heart rate recordings showed a clear dose-response relationship for pafenolol that could not be detected by ordinary casual readings. A daily dose of 25 mg of pafenolol significantly reduced blood pressure during the 9 hours after tablet intake (p less than 0.01), while 50 mg per day of pafenolol resulted in a significant reduction throughout the 24-hour period (p less than 0.01). The same pattern was seen for heart rate, which indicates a greater degree of beta-blockade during treatment with the higher dose. These results indicate that the tested noninvasive equipment is a useful tool for monitoring ambulatory 24- hour blood pressure. It gives important information impossible to obtain from single casual readings. This noninvasive method should be further evaluated to define its place in clinical work and as a research tool.

This article has been cited by other articles:

				D. A. Wittrock and E. B. Blanchard Thermal Biofeedback Treatment of Mild Hypertension: A Comparison of Effects on Conventional and Ambulatory Blood Pressure Measures Behav Modif, July 1, 1992; 16(3): 283 - 304. [Abstract] [PDF]